CNNMoney
Shares of Hi-Tech Pharmacal (NASDAQ:HITK) Co. rallied Thursday after the company said the Food and Drug Administration had granted tentative approval for the Abbreviated New Drug Application for its dorzolamide hydrochloride with timolol maleate ophthalmic solution.